Rettenmaier M - Search Results

1

Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer.

Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Micha JP, et al. Among authors: rettenmaier ma. J Oncol Pharm Pract. 2024 Apr;30(3):547-551. doi: 10.1177/10781552241232701. Epub 2024 Feb 25. J Oncol Pharm Pract. 2024. PMID: 38404005 Review.

2

Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancer.

Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Micha JP, et al. Among authors: rettenmaier ma. J Robot Surg. 2024 Feb 17;18(1):80. doi: 10.1007/s11701-024-01832-x. J Robot Surg. 2024. PMID: 38366169 Review.

3

Reply to the letter to the editor: a response to Tran and Egilman.

Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Micha JP, et al. Among authors: rettenmaier ma. Arch Gynecol Obstet. 2024 Feb;309(2):727-728. doi: 10.1007/s00404-023-07013-9. Epub 2023 Apr 6. Arch Gynecol Obstet. 2024. PMID: 37022347 No abstract available.

4

Prolonged endocrine therapy in the management of hormone receptor-positive early-stage breast cancer: What is the appropriate duration?

Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Micha JP, et al. Among authors: rettenmaier ma. J Obstet Gynaecol Res. 2023 Apr;49(4):1079-1082. doi: 10.1111/jog.15553. Epub 2023 Feb 1. J Obstet Gynaecol Res. 2023. PMID: 36725670 Review.

5

A phase II, open-label, non-randomized, prospective study assessing paclitaxel, carboplatin and metformin in the treatment of advanced stage ovarian carcinoma.

Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Micha JP, et al. Among authors: rettenmaier ma. J Gynecol Oncol. 2023 Mar;34(2):e15. doi: 10.3802/jgo.2023.34.e15. Epub 2022 Dec 6. J Gynecol Oncol. 2023. PMID: 36509462 Free PMC article. Clinical Trial.

6

Hormone Therapy and Risk of Breast Cancer: Where Are We Now?

Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Micha JP, et al. Among authors: rettenmaier ma. J Menopausal Med. 2022 Aug;28(2):47-51. doi: 10.6118/jmm.21035. J Menopausal Med. 2022. PMID: 36070869 Free PMC article. Review.

7

Robotic-Assisted Surgery for the Treatment of Breast and Cervical Cancers.

Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Micha JP, et al. Among authors: rettenmaier ma. JSLS. 2022 Apr-Jun;26(2):e2022.00014. doi: 10.4293/JSLS.2022.00014. JSLS. 2022. PMID: 35815331 Free PMC article. Review.

8

Talc powder and ovarian cancer: what is the evidence?

Micha JP, Rettenmaier MA, Bohart R, Goldstein BH. Micha JP, et al. Among authors: rettenmaier ma. Arch Gynecol Obstet. 2022 Oct;306(4):931-933. doi: 10.1007/s00404-022-06539-8. Arch Gynecol Obstet. 2022. PMID: 35348830

9

Oncolytic viral therapy engenders a clinical response in a recurrent ovarian cancer patient.

Micha J, Rettenmaier M, Giuliano P, Bohart R, Goldstein B. Micha J, et al. Among authors: rettenmaier m. Anticancer Drugs. 2022 Jun 1;33(5):513-516. doi: 10.1097/CAD.0000000000001296. Anticancer Drugs. 2022. PMID: 35324520

10

Communication via motion - Suitability of automated vehicle movements to negotiate the right of way in road bottleneck scenarios.

Rettenmaier M, Dinkel S, Bengler K. Rettenmaier M, et al. Appl Ergon. 2021 Sep;95:103438. doi: 10.1016/j.apergo.2021.103438. Epub 2021 Apr 23. Appl Ergon. 2021. PMID: 33895469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page